MiMedx Group (MDXG) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

MiMedx Group Revenue Highlights

Latest Revenue (Y)

$348.88M

Latest Revenue (Q)

$98.61M

Main Segment (Y)

Surgical

Main Geography (Y)

Health Care

MiMedx Group Revenue by Period

MiMedx Group Revenue by Year

Date	Revenue	Change
2024-12-31	$348.88M	8.52%
2023-12-31	$321.48M	20.03%
2022-12-31	$267.84M	3.57%
2021-12-31	$258.62M	4.18%
2020-12-31	$248.23M	-17.05%
2019-12-31	$299.25M	-16.67%
2018-12-31	$359.11M	11.82%
2017-12-31	$321.14M	31.07%
2016-12-31	$245.01M	30.82%
2015-12-31	$187.30M	58.43%
2014-12-31	$118.22M	99.77%
2013-12-31	$59.18M	118.75%
2012-12-31	$27.05M	248.61%
2011-12-31	$7.76M	883.74%
2010-12-31	$788.87K	100.00%
2009-12-31	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	-

MiMedx Group generated $348.88M in revenue during NA 2024, up 8.52% compared to the previous quarter, and up 116.58% compared to the same period a year ago.

MiMedx Group Revenue by Quarter

Date	Revenue	Change
2025-06-30	$98.61M	11.79%
2025-03-31	$88.20M	-5.06%
2024-12-31	$92.91M	10.53%
2024-09-30	$84.06M	-3.61%
2024-06-30	$87.21M	2.95%
2024-03-31	$84.71M	-2.44%
2023-12-31	$86.83M	6.27%
2023-09-30	$81.71M	0.56%
2023-06-30	$81.26M	13.37%
2023-03-31	$71.68M	-3.63%
2022-12-31	$74.38M	9.88%
2022-09-30	$67.69M	1.21%
2022-06-30	$66.88M	13.57%
2022-03-31	$58.89M	-12.63%
2021-12-31	$67.41M	6.87%
2021-09-30	$63.07M	-7.47%
2021-06-30	$68.17M	13.67%
2021-03-31	$59.97M	-12.52%
2020-12-31	$68.55M	6.60%
2020-09-30	$64.30M	19.86%
2020-06-30	$53.65M	-13.10%
2020-03-31	$61.74M	-19.19%
2019-12-31	$76.40M	-14.02%
2019-09-30	$88.86M	31.77%
2019-06-30	$67.44M	1.33%
2019-03-31	$66.56M	-28.12%
2018-12-31	$92.59M	6.47%
2018-09-30	$86.96M	-8.86%
2018-06-30	$95.42M	13.39%
2018-03-31	$84.15M	-3.88%
2017-12-31	$87.55M	3.52%
2017-09-30	$84.57M	10.68%
2017-06-30	$76.41M	5.24%
2017-03-31	$72.61M	3.91%
2016-12-31	$69.88M	8.45%
2016-09-30	$64.43M	12.36%
2016-06-30	$57.34M	7.45%
2016-03-31	$53.37M	2.96%
2015-12-31	$51.84M	5.75%
2015-09-30	$49.02M	7.30%
2015-06-30	$45.68M	12.05%
2015-03-31	$40.77M	3.02%
2014-12-31	$39.57M	18.07%
2014-09-30	$33.52M	31.07%
2014-06-30	$25.57M	30.75%
2014-03-31	$19.56M	8.70%
2013-12-31	$17.99M	11.65%
2013-09-30	$16.12M	19.25%
2013-06-30	$13.51M	16.95%
2013-03-31	$11.56M	9.96%
2012-12-31	$10.51M	32.13%
2012-09-30	$7.95M	62.85%
2012-06-30	$4.88M	31.80%
2012-03-31	$3.71M	40.61%
2011-12-31	$2.64M	22.46%
2011-09-30	$2.15M	11.54%
2011-06-30	$1.93M	84.90%
2011-03-31	$1.04M	327.80%
2010-12-31	$243.92K	125.79%
2010-09-30	$108.03K	-66.46%
2010-06-30	$322.07K	180.42%
2010-03-31	$114.86K	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	100.00%
2007-09-30	-	-

MiMedx Group generated $98.61M in revenue during Q2 2025, up 11.79% compared to the previous quarter, and up 116.40% compared to the same period a year ago.

MiMedx Group Revenue Breakdown

MiMedx Group Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 22	Dec 21
Surgical	$117.88M	-	-
Advanced Wound Care, Tissue And Other	-	$241.99M	$216.42M
Section 351	-	$2.38M	$17.60M
Advanced Wound Care, Umbilical Cord-Derived	-	$23.21M	$23.60M
Health Care	-	$265.20M	$240.02M
Product and Service, Other	-	$259.00K	$988.00K

MiMedx Group's latest annual revenue breakdown by segment (product or service), as of Dec 24: Surgical (100.00%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
Surgical	$34.13M	$32.13M	$31.55M	$29.00M	$29.66M	$27.66M	-	-	-	-	-	-	-	-	-	-
Advanced Wound Care	-	-	-	-	-	-	$81.64M	$81.24M	$71.21M	$66.81M	-	-	-	-	-	-
Advanced Wound Care, Umbilical Cord-Derived	-	-	-	-	-	-	$6.07M	$5.75M	$5.44M	$6.01M	$5.70M	$5.90M	$5.60M	$6.50M	$6.20M	$5.90M
Product and Service, Other	-	-	-	-	-	-	$100.00K	$29.00K	$84.00K	$78.00K	$68.00K	$74.00K	$303.00K	$313.00K	-	-
Section 351	-	-	-	-	-	-	$76.00K	$19.00K	$466.00K	$600.00K	$400.00K	$400.00K	$500.00K	$8.60M	-	-
Advanced Wound Care, Tissue And Other	-	-	-	-	-	-	$75.57M	$75.49M	$65.77M	$67.74M	$61.13M	$60.27M	$52.85M	$60.41M	$56.03M	$53.41M
Health Care	-	-	-	-	-	-	-	-	-	-	-	$66.16M	$58.45M	$66.91M	$62.28M	$59.29M

MiMedx Group's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Surgical (100.00%).

MiMedx Group Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 21
Product and Service, Other	$259.00K	$988.00K
Advanced Wound Care, Tissue And Other	$241.99M	$216.42M
Advanced Wound Care, Umbilical Cord-Derived	$23.21M	$23.60M
Health Care	$265.20M	$240.02M
Section 351	$2.38M	$17.60M

MiMedx Group's latest annual revenue breakdown by geography, as of Dec 22: Health Care (49.75%), Advanced Wound Care, Tissue And Other (45.40%), Advanced Wound Care, Umbilical Cord-Derived (4.35%), Section 351 (0.45%), and Product and Service, Other (0.05%).

MiMedx Group Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
INVA	Innoviva	$358.71M	$88.63M
MDXG	MiMedx Group	$348.88M	$98.61M
ANAB	AnaptysBio	$91.28M	$27.77M
TNGX	Tango Therapeutics	$42.07M	$3.18M
RLAY	Relay Therapeutics	$10.01M	$7.68M
PGEN	Precigen	$3.92M	$856.00K
SEPN	Septerna	$1.07M	$219.00K
PROK	ProKidney	$76.00K	$221.00K
RAPP	Rapport Therapeutics	-	-
BCAX	Bicara Therapeutics	-	-
MNMD	Mind Medicine (MindMed)	-	-

MDXG Revenue FAQ

What is MiMedx Group’s yearly revenue?

MiMedx Group's yearly revenue for 2024 was $348.88M, representing an increase of 8.52% compared to 2023. The company's yearly revenue for 2023 was $321.48M, representing an increase of 20.03% compared to 2022. MDXG's yearly revenue for 2022 was $267.84M, representing an increase of 3.57% compared to 2021.

What is MiMedx Group’s quarterly revenue?

MiMedx Group's quarterly revenue for Q2 2025 was $98.6M, a 11.79% increase from the previous quarter (Q1 2025), and a 13.07% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $88.2M, a -5.06% decrease from the previous quarter (Q4 2024), and a 4.13% increase year-over-year (Q1 2024). MDXG's quarterly revenue for Q4 2024 was $92.91M, a 10.53% increase from the previous quarter (Q3 2024), and a 7.00% increase year-over-year (Q4 2023).

What is MiMedx Group’s revenue growth rate?

MiMedx Group's revenue growth rate for the last 3 years (2022-2024) was 30.26%, and for the last 5 years (2020-2024) was 40.54%.

What are MiMedx Group’s revenue streams?

MiMedx Group's revenue streams in c 24 are Surgical

What is MiMedx Group’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of MiMedx Group was Surgical. This segment made a revenue of $117.88M, representing 100.00% of the company's total revenue.